Childhood acute myeloid leukemia (Q37174523)

18 August 2017

1 reference

title

Childhood acute myeloid leukemia (English)

1 reference

childhood acute myeloid leukemia

18 August 2017

1 reference

1 reference

Jeffrey E Rubnitz

1

1 reference

18 August 2017

1 February 2008

1 reference

Current Treatment Options in Oncology

18 August 2017

1 reference

18 August 2017

9

1 reference

18 August 2017

1

1 reference

18 August 2017

95-105

1 reference

https://scigraph.springernature.com/pub.10.1007/s11864-008-0059-z

18 August 2017

0 references

cites work

Determinants of antileukemia effects of allogeneic NK cells

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11864-008-0059-Z

Comparison of killer Ig-like receptor genotyping and phenotyping for selection of allogeneic blood stem cell donors.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11864-008-0059-Z

FLT3 internal tandem duplication in CD34+/CD33- precursors predicts poor outcome in acute myeloid leukemia

21 January 2018

1 reference

12 December 2020

Ethnicity and survival in childhood acute myeloid leukemia: a report from the Children's Oncology Group

1 reference

12 December 2020

Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study

1 reference

12 December 2020

Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?

1 reference

12 December 2020

Impact of age on outcome of pediatric acute myeloid leukemia: a report from 2 institutions

1 reference

12 December 2020

Outcome in children with relapsed acute myeloid leukemia after initial treatment with the French Leucemie Aique Myeloide Enfant (LAME) 89/91 protocol of the French Society of Pediatric Hematology and Immunology

1 reference

12 December 2020

Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification?

1 reference

12 December 2020

Gene expression profiling of pediatric acute myelogenous leukemia

1 reference

12 December 2020

The clinical spectrum of adult acute myeloid leukaemia associated with core binding factor translocations

1 reference

12 December 2020

Successive clinical trials for childhood acute myeloid leukemia at St Jude Children's Research Hospital, from 1980 to 2000.

1 reference

12 December 2020

Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000.

1 reference

12 December 2020

Prognostic value of minimal residual disease (MRD) in acute myeloid leukemia (AML) with favorable cytogenetics [t(8;21) and inv(16)].

1 reference

12 December 2020

Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors

1 reference

12 December 2020

Outcomes in CCG-2961, a children's oncology group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the children's oncology group

1 reference

12 December 2020

Determination of minimal residual disease in leukaemia patients

1 reference

12 December 2020

Monosomy 7 and deletion 7q in children and adolescents with acute myeloid leukemia: an international retrospective study

1 reference

12 December 2020

Microbiologically documented infections and infection-related mortality in children with acute myeloid leukemia

1 reference

12 December 2020

Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT.

1 reference

12 December 2020

An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells.

1 reference

12 December 2020

Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials

1 reference

12 December 2020

Prognostic factors and outcome of recurrence in childhood acute myeloid leukemia

1 reference

12 December 2020

Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value.

1 reference

12 December 2020

Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia

1 reference

12 December 2020

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the Unite

1 reference

12 December 2020

Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia

1 reference

12 December 2020

Single-agent CEP-701, a novel FLT3 inhibitor, shows biologic and clinical activity in patients with relapsed or refractory acute myeloid leukemia

1 reference

12 December 2020

Gene expression profiles at diagnosis in de novo childhood AML patients identify FLT3 mutations with good clinical outcomes

1 reference

12 December 2020

Mitoxantrone and cytarabine induction, high-dose cytarabine, and etoposide intensification for pediatric patients with relapsed or refractory acute myeloid leukemia: Children's Cancer Group Study 2951.

1 reference

12 December 2020

Death during induction therapy and first remission of acute leukemia in childhood: the St. Jude experience

1 reference

12 December 2020

Clinical implications of FLT3 mutations in pediatric AML.

1 reference

12 December 2020

Clofarabine, a novel nucleoside analog, is active in pediatric patients with advanced leukemia

1 reference

12 December 2020

Clinical significance of residual disease during treatment in childhood acute myeloid leukaemia

1 reference

12 December 2020

Duration of first remission predicts remission rates and long-term survival in children with relapsed acute myelogenous leukemia

1 reference

12 December 2020

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer

1 reference

12 December 2020

The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties

1 reference

12 December 2020

Pediatric acute myeloid leukemia: international progress and future directions

1 reference

12 December 2020

Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway

1 reference

12 December 2020

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

1 reference

12 December 2020

Biology and outcome of childhood acute megakaryoblastic leukemia: a single institution's experience

1 reference

12 December 2020

Effect of race on outcome of white and black children with acute myeloid leukemia: the St. Jude experience.

1 reference

12 December 2020

Prophylactic human granulocyte colony-stimulating factor after induction therapy in pediatric acute myeloid leukemia.

1 reference

12 December 2020

Early peripheral blood blast clearance during induction chemotherapy for acute myeloid leukemia predicts superior relapse-free survival

1 reference

12 December 2020

Preferential induction of apoptosis for primary human leukemic stem cells

1 reference

12 December 2020

Results of consecutive trials for children newly diagnosed with acute myeloid leukemia from the Australian and New Zealand Children's Cancer Study Group.

1 reference

12 December 2020

Long-term results of children with acute myeloid leukemia: a report of three consecutive Phase III trials by the Children's Cancer Group: CCG 251, CCG 213 and CCG 2891.

1 reference

12 December 2020

Exploiting signal transduction pathways in acute myelogenous leukemia

1 reference

12 December 2020

Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes.

1 reference

12 December 2020

Focus on acute leukemias

1 reference

12 December 2020

Rapid and selective death of leukemia stem and progenitor cells induced by the compound 4-benzyl, 2-methyl, 1,2,4-thiadiazolidine, 3,5 dione (TDZD-8)

1 reference

12 December 2020

Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials

1 reference

12 December 2020

A feasibility study of simultaneous administration of gemtuzumab ozogamicin with intensive chemotherapy in induction and consolidation in younger patients with acute myeloid leukemia

1 reference

12 December 2020

Outcome for children with relapsed acute myeloid leukaemia following initial therapy in the Medical Research Council (MRC) AML 10 trial. MRC Childhood Leukaemia Working Party

1 reference

12 December 2020

Mortality in overweight and underweight children with acute myeloid leukemia

1 reference

12 December 2020

Activating mutations of RTK/ras signal transduction pathway in pediatric acute myeloid leukemia

1 reference

12 December 2020

Acute megakaryoblastic leukemia in children and adolescents, excluding Down's syndrome: improved outcome with intensified induction treatment

1 reference

12 December 2020

Immunophenotypic evidence of leukemia after induction therapy predicts relapse: results from a prospective Children's Cancer Group study of 252 patients with acute myeloid leukemia

1 reference

12 December 2020

Novel therapies targeting the apoptosis pathway for the treatment of acute myeloid leukemia

1 reference

12 December 2020

Favorable impact of the t(9;11) in childhood acute myeloid leukemia

1 reference

12 December 2020

10.1007/S11864-008-0059-Z

Identifiers

DOI

1 reference

release_csa3naq6afg3jboluvkocvgq2q

18 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/csa3naq6afg3jboluvkocvgq2q

24 November 2022

mapped directly with Wikidata item

PubMed ID

18506629

1 reference

PubMed ID

18506629